The Dahl salt-sensitive rat is a spontaneous model of superimposed preeclampsia

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 309, Issue 1, 2015, Pages R62-R70

  Gillis, Ellen E ^a   Williams, Jan M ^a   Garrett, Michael R ^a,b   Mooney, Jennifer N ^a   Sasser, Jennifer M ^a  

^a Department of Pharmacology and Toxicology ^*  (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Animal model; HIF 1 ; Hypertension; Pregnancy; Proteinuria; sFLT 1; Superimposed preeclampsia; TNF ; Uterine artery resistance

Indexed keywords

PROTEIN TYROSINE KINASE; SOLUBLE FMS LIKE TYROSINE KINASE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; FLT1 PROTEIN, RAT; HIF1A PROTEIN, RAT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TUMOR NECROSIS FACTOR; VASCULOTROPIN RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY RESISTANCE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DAHL SALT SENSITIVE RAT; FEMALE; GLOMERULOMEGALY; GLOMERULOPATHY; HYPERTENSION; HYPOXIA; LITTER SIZE; MEAN ARTERIAL PRESSURE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PLACENTAL HYPOXIA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SPRAGUE DAWLEY RAT; TELEMETRY; THIRD TRIMESTER PREGNANCY; URINARY EXCRETION; UTERINE ARTERY; ANIMAL; ARTERIAL PRESSURE; COMPARATIVE STUDY; DAHL RAT; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; INTRAUTERINE GROWTH RETARDATION; KIDNEY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PRE-ECLAMPSIA; PROTEINURIA; SPECIES DIFFERENCE; TIME FACTOR; VASCULAR RESISTANCE;

ANIMALS; ARTERIAL PRESSURE; DISEASE MODELS, ANIMAL; FEMALE; FETAL GROWTH RETARDATION; GENETIC PREDISPOSITION TO DISEASE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY; PHENOTYPE; PRE-ECLAMPSIA; PREGNANCY; PROTEINURIA; RATS, INBRED DAHL; RATS, INBRED SHR; SPECIES SPECIFICITY; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UTERINE ARTERY; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR RESISTANCE;

EID: 84935479383     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00377.2014     Document Type: Article

References (51)

1. Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res 95: 884–891, 2004.
2. Ain R, Konno T, Canham LN, Soares MJ. Phenotypic analysis of the rat placenta. Methods Mol Med 121: 295–313, 2006.
3. Alexander BT, Kassab SE, Miller MT, Abram SR, Reckelhoff JF, Bennett WA, Granger JP. Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. Hypertension 37: 1191–1195, 2001.
4. Aoi W, Gable D, Cleary RE, Young PC, Weinberger MH. The antihypertensive effect of pregnancy in spontaneously hypertensive rats. Proc Soc Exp Biol Med 153: 13–15, 1976.
5. Baylis C. Immediate and long-term effects of pregnancy on glomerular function in the SHR. Am J Physiol Renal Fluid Electrolyte Physiol 257: F1140–F1145, 1989.
6. Benyo DF, Miles TM, Conrad KP. Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab 82: 1582–1588, 1997.
7. Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 86: 2505–2512, 2001.
8. Chappell LC, Enye S, Seed P, Briley AL, Poston L, Shennan AH. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension 51: 1002–1009, 2008.
9. Chen PY, Sanders PW. L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest 88: 1559–1567, 1991.
10. Chen PY, Sanders PW. Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats. Hypertension 22: 812–818, 1993.
11. Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 40: 102–111, 1998.
12. Creasy R, Resnik R, Iams JD, Lockwood CJ, Moore T, Greene MF. Creasy and Resnik’s Maternal-Fetal Medicine. Principles and Practice (7th ed.) Elsevier Health Sciences, 2014.
13. Davis EF, Lazdam M, Lewandowski AJ, Worton SA, Kelly B, Ken-worthy Y, Adwani S, Wilkinson AR, McCormick K, Sargent I, Redman C, Leeson P. Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics 129: e1552–e1561, 2012.
14. Davisson RL, Hoffmann DS, Butz GM, Aldape G, Schlager G, Merrill DC, Sethi S, Weiss RM, Bates JN. Discovery of a spontaneous genetic mouse model of preeclampsia. Hypertension 39: 337–342, 2002.
15. Deng A, Engels K, Baylis C. Impact of nitric oxide deficiency on blood pressure and glomerular hemodynamic adaptations to pregnancy in the rat. Kidney Int 50: 1132–1138, 1996.
16. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 9: 147–160, 2002.
17. Hladunewich M, Karumanchi SA, Lafayette R. Pathophysiology of the clinical manifestations of preeclampsia. Clin J Am Soc Nephrol 2: 543–549, 2007.
18. Holemans K, Aerts L, Van Assche FA. Fetal growth restriction and consequences for the offspring in animal models. J Soc Gynecol Invest 10: 392–399, 2003.
19. Iacono A, Bianco G, Mattace Raso G, Esposito E, d’Emmanuele di Villa Bianca R, Sorrentino R, Cuzzocrea S, Calignano A, Autore G, and Meli R. Maternal adaptation in pregnant hypertensive rats: improvement of vascular and inflammatory variables and oxidative damage in the kidney. Am J Hypertens 22: 777–783, 2009.
20. LaMarca B, Speed J, Fournier L, Babcock SA, Berry H, Cockrell K, Granger JP. Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade. Hypertension 52: 1161–1167, 2008.
21. LaMarca BBD, Bennett a W, Alexander BT, Cockrell K, Granger JP. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. Hypertension 46: 1022–1025, 2005.
22. Lumey LH. Compensatory placental growth after restricted maternal nutrition in early pregnancy. Placenta 19: 105–111, 1998.
23. Maruotti GM, Sarno L, Napolitano R, Mazzarelli LL, Quaglia F, Capone A, Capuano A, Martinelli P. Preeclampsia in women with chronic kidney disease. J Matern Fetal Neonatal Med 25: 1367–1369, 2012.
24. Mattson DL, James L, Berdan EA, Meister CJ. Immune suppression attenuates hypertension and renal disease in the Dahl salt-sensitive rat. Hypertension 48: 149–156, 2006.
25. Maynard SE, Min J, Merchan J, Lim K, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and pro-teinuria in preeclampsia. J Clin Invest 111: 649–658, 2003.
26. McLeod L. How useful is uterine artery Doppler ultrasonography in predicting pre-eclampsia and intrauterine growth restriction? Can Med Assoc J 178: 727–729, 2008.
27. Meng S, Roberts LJ, Cason Curry TS GW, Manning RD. Superoxide dismutase and oxidative stress in Dahl salt-sensitive and -resistant rats. Am J Physiol Regul Integr Comp Physiol 283: R732–R738, 2002.
28. De Miguel C, Das S, Lund H, Mattson DL. T lymphocytes mediate hypertension and kidney damage in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 298: R1136–R1142, 2010.
29. Naljayan MV, Karumanchi SA. New developments in the pathogenesis of preeclampsia. Adv Chronic Kidney Dis 20: 265–270, 2013.
30. Napolitano R, Santo S, D’Souza R, Bhide a Thilaganathan B. Sensitivity of higher, lower and mean second-trimester uterine artery Doppler resistance indices in screening for pre-eclampsia. Ultrasound Obstet Gynecol 36: 573–576, 2010.
31. Palei AC, Spradley FT, Warrington JP, George EM, Granger JP. Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology. Acta Physiol (Oxford) 208: 224–233, 2013.
32. Pollak VE, Nettles JB. The kidney in toxemia of pregnancy: a clinical and pathologic study based on renal biopsies. Medicine 39: 469–526, 1960.
33. Rapp JP. Dahl salt-susceptible and salt-resistant rats. A review. Hypertension 4: 753–763, 1982.
34. Risnes KR, Romundstad PR, Nilsen TIL, Eskild A, Vatten LJ. Pla-cental weight relative to birth weight and long-term cardiovascular mor- tality: findings from a cohort of 31,307 men and women. Am J Epidemiol 170: 622–631, 2009.
35. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 357: 53–56, 2001.
36. Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension 46: 1243–1249, 2005.
37. Sasser JM, Baylis C. Effects of sildenafil on maternal hemodynamics and fetal growth in normal rat pregnancy. Am J Physiol Regul Integr Comp Physiol 298: R433–R438, 2010.
38. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia Lancet 365: 785–799, 2005.
39. Sibai BM, Lindheimer M, Hauth J, Caritis S, VanDorsten P, Kle-banoff M, MacPherson C, Landon M, Miodovnik M, Paul R, Meis P, Dombrowski M. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. New Engl J Med 339: 667–671, 1998.
40. Sladek SM, Magness RR, Conrad KP. Nitric oxide and pregnancy. Am J Physiol Regul Integr Comp Physiol 272: R441–R463, 1997.
41. Steegers EP, Von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclamp-sia. Lancet 376: 631–644, 2010.
42. Stillman IE, Karumanchi SA. The glomerular injury of preeclampsia. J Am Soc Nephrol 18: 2281–2284, 2007.
43. Szentiványi M, Zou AP, Mattson DL, Soares P, Moreno C, Roman RJ, Cowley AW. Renal medullary nitric oxide deficit of Dahl S rats enhances hypertensive actions of angiotensin II. Am J Physiol Regul Integr Comp Physiol 283: R266–R272, 2002.
44. Takahashi K, Ohkuchi A, Hirashima C, Matsubara S, Suzuki M. Establishing reference values for mean notch depth index, pulsatility index and resistance index in the uterine artery at 16–23 weeks gestation. J Obstet Gynaecol Res 38: 1275–1285, 2012.
45. Takushima S, Nishi Y, Nonoshita A, Mifune H, Hirata R, Tanaka E, Doi R, Hori D, Kamura T, Ushijima K. Changes in the nitric oxide-soluble guanylate cyclase system and natriuretic peptide receptor system in placentas of pregnant Dahl salt-sensitive rats. J Obstet Gynaecol Res 41: 540–550, 2014.
46. Tam Tam KB, George E, Cockrell K, Arany M, Speed J, Martin JN, Lamarca B, Granger JP. Endothelin type A receptor antagonist attenuates placental ischemia-induced hypertension and uterine vascular resistance. Am J Obstet Gynecol 204: 330. e1–e4, 2011.
47. Taylor NE, Cowley AW. Effect of renal medullary H2O2 on salt-induced hypertension and renal injury. Am J Physiol Regul Integr Comp Physiol 289: R1573–R1579, 2005.
48. Tojo A, Onozato ML, Kobayashi N, Goto A, Matsuoka H, Fujita T. Angiotensin II and oxidative stress in Dahl Salt-sensitive rat with heart failure. Hypertension 40: 834–839, 2002.
49. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D’Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA. Soluble endoglin contributes to the patho-genesis of preeclampsia. Nature Med 12: 642–649, 2006.
50. Widmer M, Villar J, Benigni A, Conde-Agudelo A, Karumanchi SA, Lindheimer M. Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review. Obstet Gynecol 109: 168–80, 2007.
51. Yallampalli C, Garfield RE. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 169: 1316–13120, 1993.